bioplastic

Bioplastic introduces calprotectin semi-quantitative rapid test with triple threshold level

Bioplastic has released an immunochromatographic kit (monotest) for the semiquantitative determination of faecal calprotectin. Through development on the reactive card of three coloured bands, the evaluation of the concentration interval can be determined on three distinct levels depending on the combination of 3 coloured bands (T1, T2 and T3).

porvair577

Porvair introduces new version of Microlute PLR phospholipid removal microplate

Porvair Sciences has introduced a new and improved version of its Microlute PLR phospholipid removal microplate designed to enhance the flow of samples through a proprietary filter to maximise the recovery of analytes with unmatched reproducibility.

seqwel Steve Smith

seqWell makes five new appointments

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell multiplexing platform, announced five appointments to its commercial team. Led by Steve Smith, who joins as Chief Commercial Officer, the team will be responsible for driving awareness, adoption, and development of the plexWell platform and product pipeline, to provide scientists […]

saga diagnostics

SAGA Diagnostics enters into assay development agreement with AstraZeneca

SAGA Diagnostics, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with AstraZeneca, the global biopharmaceutical company.

Heiner Dreismann

Heiner Dreismann joins Noscendo’s Board of Directors

Noscendo, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections has appointed Heiner Dreismann, former President and CEO of Roche Molecular Systems, to its Board of Directors.

Mogrify Tom Graney

Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor

Mogrify, a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, has appointed Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He joins senior biopharma industry executives, Dr. Jane Osbourn OBE (Chair) and Dr. Lorenz Mayr, as […]

dotmatics logo

Dotmatics partners with RockStep Solutions to provide integrated solution for digitalized in vivo drug discovery

Dotmatics, a science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, announced a partnership with RockStep Solutions, a developer of software tools for managing data and operations for in vivo research. The collaboration combines the simple, unified, realtime access to all research data […]

dna

BioNet and BIA Separations collaborate on production process development of mRNA vaccines

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.

BIOFORTUNA

Biofortuna doubles their manufacturing space to meet demand

Biofortuna, a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.

aragen

Aragen expects to ride wave of US biotech growth in 2022 on back of demand for CDMO services

Hyderabad, India-based Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at around 40% year-on-year.